Trauma — Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study
Citation(s)
Abzug JM, Herman MJ Management of supracondylar humerus fractures in children: current concepts. J Am Acad Orthop Surg. 2012 Feb;20(2):69-77. doi: 10.5435/JAAOS-20-02-069. Review.
Blasier RD Gartland type-II supracondylar humeral fractures in children: commentary on an article by Luis Moraleda, MD, et al.: "Natural history of unreduced Gartland type-II supracondylar fractures of the humerus in children. a two to thirteen-year follow-up study". J Bone Joint Surg Am. 2013 Jan 2;95(1):e7.
Cheng JC, Lam TP, Shen WY Closed reduction and percutaneous pinning for type III displaced supracondylar fractures of the humerus in children. J Orthop Trauma. 1995;9(6):511-5.
Daltroy LH, Liang MH, Fossel AH, Goldberg MJ The POSNA pediatric musculoskeletal functional health questionnaire: report on reliability, validity, and sensitivity to change. Pediatric Outcomes Instrument Development Group. Pediatric Orthopaedic Society of North America. J Pediatr Orthop. 1998 Sep-Oct;18(5):561-71.
Flynn JC, Matthews JG, Benoit RL Blind pinning of displaced supracondylar fractures of the humerus in children. Sixteen years' experience with long-term follow-up. J Bone Joint Surg Am. 1974 Mar;56(2):263-72.
Hadlow AT, Devane P, Nicol RO A selective treatment approach to supracondylar fracture of the humerus in children. J Pediatr Orthop. 1996 Jan-Feb;16(1):104-6.
Moraleda L, Valencia M, Barco R, González-Moran G Natural history of unreduced Gartland type-II supracondylar fractures of the humerus in children: a two to thirteen-year follow-up study. J Bone Joint Surg Am. 2013 Jan 2;95(1):28-34.
Mulpuri K, Hosalkar H, Howard A AAOS clinical practice guideline: the treatment of pediatric supracondylar humerus fractures. J Am Acad Orthop Surg. 2012 May;20(5):328-30. doi: 10.5435/JAAOS-20-05-328.
O'Hara LJ, Barlow JW, Clarke NM Displaced supracondylar fractures of the humerus in children. Audit changes practice. J Bone Joint Surg Br. 2000 Mar;82(2):204-10.
Pirone AM, Graham HK, Krajbich JI Management of displaced extension-type supracondylar fractures of the humerus in children. J Bone Joint Surg Am. 1988 Jun;70(5):641-50. Erratum in: J Bone Joint Surg [Am] 1988 Aug;70(7):1114.
Williamson DM, Cole WG Treatment of selected extension supracondylar fractures of the humerus by manipulation and strapping in flexion. Injury. 1993 Apr;24(4):249-52.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
